The potential and pitfalls of artificial intelligence in clinical pharmacology

被引：14
|
作者：
Johnson, Martin [1 ]
Patel, Mishal [2 ]
Phipps, Alex [1 ]
Van der Schaar, Mihaela [3 ,4 ]
Boulton, Dave [5 ]
Gibbs, Megan [5 ]
机构：
[1] AstraZeneca, Clin Pharmacol & Quantitat Pharmacol, Clin Pharmacol & Safety Sci, R&D, Cambridge, England
[2] AstraZeneca, Clin Pharmacol & Quantitat Pharmacol, Artificial Intelligence & Data Analyt, R&D, Cambridge, England
[3] Univ Cambridge, Cambridge Ctr Artificial Intelligence Med, Dept Appl Math & Theoret Phys, Cambridge, England
[4] Univ Cambridge, Dept Populat Hlth, Cambridge, England
[5] AstraZeneca, Clin Pharmacol & Quantitat Pharmacol, Clin Pharmacol & Safety Sci, R&D, 1 Medimmune Way, Gaithersburg, MD 20878 USA
来源：
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY | 2023年 / 12卷 / 03期
关键词：
D O I：
10.1002/psp4.12902
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Artificial intelligence (AI) involves using data and algorithms to perform activities normally achieved through human intelligence. AI and its key component machine learning contextualize data and enhance decision making to transform how we operate, discover, and develop drugs. Transforming clinical pharmacology (CP) as AI-augmented CP (AI/CP) requires an ecosystem including digitized data collection, standardized processes, complementary technologies, and an ethical framework. This commentary aims to highlight the future perspectives of AI/CP in drug development.
引用
收藏
页码：279 / 284
页数：6
相关论文
共 50 条
  • [1] Artificial intelligence in geriatric medicine: Potential and pitfalls
    Stefanacci, Richard G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 (11) : 3651 - 3652
  • [2] Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists
    Singh, Harmanjit
    Nim, Dwividendra Kumar
    Randhawa, Aaronbir Singh
    Ahluwalia, Saher
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2024, 17 (04) : 381 - 391
  • [3] Artificial intelligence in clinical pharmacology: Applications and limitations
    Prada-Ramallal, Guillermo
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 49 - 50
  • [4] Artificial intelligence and machine learning for clinical pharmacology
    Ryan, David K.
    Maclean, Rory H.
    Balston, Alfred
    Scourfield, Andrew
    Shah, Anoop D.
    Ross, Jack
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 629 - 639
  • [5] Ethics for artificial intelligence use in clinical pharmacology
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (03) : 224 - 225
  • [6] Promises, Pitfalls, and Clinical Applications of Artificial Intelligence in Pediatrics
    Bhargava, Hansa
    Salomon, Carmela
    Suresh, Srinivasan
    Chang, Anthony
    Kilian, Rachel
    van Stijn, Diana
    Oriol, Albert
    Low, Daniel
    Knebel, Ashley
    Taraman, Sharief
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2024, 26
  • [7] Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
    Zhavoronkov, Alex
    Vanhaelen, Quentin
    Oprea, Tudor I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 780 - 785
  • [8] Artificial intelligence: advances and pitfalls
    Falk Schwendicke
    Martha Büttner
    British Dental Journal, 2023, 234 : 749 - 750
  • [9] Artificial intelligence: advances and pitfalls
    Schwendicke, Falk
    Buettner, Martha
    BRITISH DENTAL JOURNAL, 2023, 234 (10) : 749 - 750
  • [10] Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology
    Shahin, Mohamed H.
    Barth, Aline
    Podichetty, Jagdeep T.
    Liu, Qi
    Goyal, Navin
    Jin, Jin Y.
    Ouellet, Daniele
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (04) : 698 - 709
12345